Introduction {#j_jomb-2016-0015_s_001}
============

Systemic inflammatory response syndrome (SIRS) represents an inflammatory condition that spreads all over the body. SIRS is most frequently caused by infection or sepsis. In comparison to the general term infection, sepsis is a condition in which the patient fulfills the criteria for SIRS, and has a known or very certain infection. SIRS is a serious condition that is related to systemic inflammation, organ dysfunction and complete cessation of functions. SIRS is considered a part of the ≫cytokine storm≪, and is manifested by the dysregulation of different cytokines (1). The American College of Chest Physicians (ACCP) and the Society of Critical Care Medicine (SCCM) defined SIRS using the following criteria: body temperature below 36 °C or over 38 °C, heart rate over 90 per minute, tachypnea over 20 respirations per minute or carbon dioxide partial pressure below 4.3 kPa (32 mmHg), and leukocyte number lower than 4000 cells/mm (4 × 10^9^ cells/L) or over 12.000 cells/mm (12 × 10^9^ cells/L), or presence of over 10% of immature neutrophils [@j_jomb-2016-0015_ref_001]. The same societies accepted that severity of the disease is best predicted using the Acute Physiology and Chronic Health Evaluation II (APACHE II) score [@j_jomb-2016-0015_ref_002] while the patient's outcome, namely organ dysfunction/failure during Intensive Care Unit (ICU) monitoring, is predicted using the Sequential Organ Failure Assessment (SOFA) score [@j_jomb-2016-0015_ref_003].

Systemic inflammatory response leads to significant changes in the concentrations of different hormones. Among them, the most characteristic is the cortisol change dynamics indicating dissociation between the adrenal cortex and the hypothalamopituitary unit. This is manifested by very high concentrations of cortisol and ACTH immediately after the initiation of SIRS. A few days later, however, ACTH falls to a very low concentration while the concentration of cortisol remains high [@j_jomb-2016-0015_ref_004]. This is explained by the direct effect of cytokines on the adrenal cortex stimulating glucocorticoid release [@j_jomb-2016-0015_ref_005].

Cortisol response to stimulation with ACTH was shown to be an important predictor in critically ill patients [@j_jomb-2016-0015_ref_006]. Patients with an inadequate cortisol response to stimulation with ACTH had a high mortality rate. The use of ACTH test, however, has not been standardized till now and has not been performed over different periods beginning with the onset of an inflammatory condition. Stimulation with 250 μg of ACTH is considered to be a standard test for the assessment of adrenal function ([@j_jomb-2016-0015_ref_007], [@j_jomb-2016-0015_ref_008]). The low-dose (1 μg) test (LDT), however, represents a more sensitive method for detecting specific forms of adrenal insufficiency such as hypothalamo-pituitary dysfunction ([@j_jomb-2016-0015_ref_009], [@j_jomb-2016-0015_ref_010]). The use of LDT in critically ill patients is not clearly defined as the data on LDT are limited and insufficient for a clear recommendation ([@j_jomb-2016-0015_ref_011]--[@j_jomb-2016-0015_ref_013]).

It is known that the response of cortisol to ACTH stimulation depends on the period that has elapsed since the occurrence of inflammation [@j_jomb-2016-0015_ref_006]. The aim of this study was to assess the response of the adrenal cortex after stimulation with synthetic ACTH in patients with SIRS at admission to the Intensive Care Unit (ICU) and seven days later, and to follow the outcome of ICU hospitalization.

Materials and Methods {#j_jomb-2016-0015_s_002}
=====================

Study population {#j_jomb-2016-0015_s_002_s_001}
----------------

Fifty-four consecutive patients (37 males, 17 females) were included in the study. All the investigated subjects were referred to the University Medical Center (UMC) ≫Bežanijska kosa≪, Belgrade, due to the presence of fever, dyspnea and poor general condition. All of the patients were of Caucasian origin, with no history of malignant disease and previous therapy with ketoconazole, etomidate, and glucocorticoids. After the initial examination, most of the patients were admitted to the Respiratory Intensive Care Unit (RICU) of the UMC. If the patient was initially admitted to the Department of Pulmonology, but his clinical state soon deteriorated, he or she was transferred to the RICU. At admission to the RICU, vital status was assessed in all the patients, including state of consciousness, systemic arterial blood pressure and heart rate, and body temperature. In all the patients, community acquired pneumonia was confirmed.

SIRS was defined according to the 1992 ACCP/SCCM Consensus Conference [@j_jomb-2016-0015_ref_001] when the condition met two or more of the given criteria (assessment of body temperature using the Celsius Scale, determination of heart rate and number of respirations per minute, and leukocyte concentration in the blood).

Data collection {#j_jomb-2016-0015_s_002_s_002}
---------------

*Clinical evaluation*. At the onset of SIRS, the following variables were recorded: [@j_jomb-2016-0015_ref_001] general characteristics including age and sex, date of RICU admission; [@j_jomb-2016-0015_ref_002] severity of disease as determined using the APACHE II score (age, history of severe organ insufficiency or being immunocompromised, rectal temperature, mean arterial pressure, heart rate, respiratory rate, oxygenation, arterial pH, serum sodium, potassium and creatinine, hematocrit, white blood cell count and Glasgow Coma Scale score); [@j_jomb-2016-0015_ref_003] mortality prediction based on the degree of dysfunction of six organ systems using the SOFA score (oxygenation, platelets count, Glasgow Coma Scale score, bilirubin, mean arterial pressure and creatinine); [@j_jomb-2016-0015_ref_004] need for and length of mechanical ventilation, number of days spent in the RICU, and the outcome of SIRS (survived or non-survived).

The APACHE II score is expressed in points from 0 to 71, and a higher score implies more severe disease and higher mortality risk. The SOFA score is used in monitoring patient status during the stay in the ICU. Both APACHE II and SOFA provide an estimate of disease severity and mortality during stay in the ICU based on a number of the abovementioned laboratory values and patient signs, taking both acute and chronic disease into account.

Laboratory variables {#j_jomb-2016-0015_s_002_s_003}
--------------------

At admission to the hospital and the diagnosis of SIRS, hematologic and chemistry data, and blood gas determinations were done systematically. Low-dose ACTH test was performed in all patients immediately after the admission to the RICU and seven days later.

ACTH testing procedure {#j_jomb-2016-0015_s_002_s_004}
----------------------

At admission to the RICU, an indwelling venous catheter was placed in the antecubital vein and, in all the patients, blood samples were drawn for the determination of standard biochemical analyses, cortisol and ACTH. At least 30 min after placing the catheter, the LDT was started with an IV injection of 1 μg ACTH~1-24~ (Synacthen, Novartis Pharma Schweiz AG). Blood samples for cortisol determination were taken from the IV cannula at 0, 15 and 30 min. All blood samples were immediately separated and kept frozen at -80 ^o^C until assayed. As previously described, for the low-dose ACTH test, a vial of 250 μg Synacthen was diluted in normal saline solution to a concentration of 0.5 μg/mL [@j_jomb-2016-0015_ref_010], and the solution was used immediately.

Study protocol was approved by the Ethical Committee of the Faculty of Medicine, University of Belgrade, and informed consent was obtained from each patient or patient's next-of-kin.

Assays {#j_jomb-2016-0015_s_002_s_005}
------

Cortisol was determined using an immunoassay (Elecsys Cortisol II assay, Cobas e411 analyzer, Roche Diagnostics GmbH, Mannheim, Germany), with intra- and inter-assay CV of 1.8--7.1% and 2.7--12.7%, respectively. ACTH was also determined using an immunoassay (Elecsys ACTH assay, Cobas e411 analyzer, Roche Diagnostics GmbH, Mannheim, Germany) with intra- and inter-assay CV of 2.0--2.9% and 2.4--5.4%, respectively.

Statistical analysis {#j_jomb-2016-0015_s_002_s_006}
--------------------

Statistical analysis was performed using R [@j_jomb-2016-0015_ref_014], Vienna, Austria (<https://www.R-project.org/>). For comparison between groups, Student t test was used for two independent samples for parametric data, and χ^2^ test was employed for nonparametric data and binomial variables. Results are presented as mean ± standard deviation (x ± SD) for the continuous variables, and as percentages for the binary variables.

Zero-inflated negative binomial regression was used for modeling count variables with excessive zeros, and for overdispersed count outcome variables. We investigated the possibility of predicting whether a patient will receive mechanical ventilation during his/her stay in the RICU and for how many days, based on patient characteristics collected at the onset of SIRS presented with APACHE II and SOFA scores.

Poisson regression model was used for prediction of days spent in the RICU based on sex and maximal cortisol increase during the ACTH stimulation test.

Logistic regression analysis was performed to predict overall outcome (survival or death). Calibration of the logistic model was assessed using the Hosmer-Lemeshow goodness-of-fit test to evaluate the importance of the discrepancy between observed and expected mortality.

For all tests, P\<0.05 was considered statistically significant.

Results {#j_jomb-2016-0015_s_003}
=======

The clinical and biochemical characteristics of SIRS patients are presented in *[Table I](#j_jomb-2016-0015_tab_001){ref-type="table"}*. Respiratory infections were confirmed in all patients. Of 54 patients, 5 (9.6%) died within the 7-day period following the onset and management of SIRS in the RICU.

###### 

Clinical and biochemical characteristics of the whole group of patients at baseline and after 7 days in RICU.

  Variable                                                                     
  ----------------------------------------------------- ---------------------- ---------------
  N                                                     54                     
                                                                               
  Age (years)                                           45.25±5.45             
                                                                               
  Sex                                                                          
                                                                               
     Male, N (%)                                        37 (67.3)              
                                                                               
     Female, N (%)                                      17 (32.7)              
                                                                               
  Onset of disease (days)                               4.25±1.31              
                                                                               
  Underlying disease                                                           
                                                                               
  Community acquired pneumonia, N (%)                   48 (92.3)              
                                                                               
     ARDS, N (%)                                        3 (5.8)                
                                                                               
     Sepsis, N (%)                                      1 (1.9)                
                                                                               
  APACHE II                                                                    
                                                                               
     Point                                              15.79±6.16             
                                                                               
     %                                                  25.19±17.50            
                                                                               
  SOFA                                                                         
                                                                               
     Point                                              3.48±2.04              
                                                                               
     %                                                  11.92±7.93             
                                                                               
  Mechanical ventilation                                                       
                                                                               
     Yes / No                                           9 (16.7) / 45 (83.3)   
                                                                               
     Duration (patients on ventilation) (days)          5.14±4.49              
                                                                               
     Duration (whole group) (days)                      0.69±2.35              
                                                                               
  Outcome                                                                      
                                                                               
     Survived, N (%)                                    49 (90.4)              
                                                                               
     Died, N (%)                                        5 (9.6)                
                                                                               
                                                        Day 0                  Day 7
                                                                               
  ACTH (ng/dL)                                          6.57±7.08              6.46±8.72
                                                                               
  Synacthen test                                                               
                                                                               
     Cortisol (nmol/L), 0 min                           633.22±362.30          582.62±341.56
                                                                               
     Cortisol (nmol/L), 15 min                          832.25±311.89          805.35±328.51
                                                                               
     Cortisol (nmol/L), 30 min                          896.57±305.36          854.54±313.16
                                                                               
     Cortisol (nmol/L), 60 min                          884.69±339.29          841.11±363.53
                                                                               
     Maximal cortisol (mean)                            967.75±321.02          932.65±348.12
                                                                               
  Difference cortisol (maximal value -- basal value)    353.47±193.72          350.04±262.96
                                                                               
  Difference cortisol (maximal value -- 15 min value)   220.92±133.36          222.73±152.52
                                                                               
  Difference cortisol (maximal value -- 30 min value)   285.25±147.13          271.93±175.85
                                                                               
  Difference cortisol (maximal value -- 60 min value)   270.41±222.04          258.49±289.77
                                                                               
  Maximal cortisol (Δ max) (Day 0 -- Day 7)             582.62±341.56          

RICU, respiratory intensive care unit; ARDS, acute respiratory distress syndrome; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; ACTH, adrenocorticotropin.

In respect to hormonal analysis, we evaluated both the basal values of ACTH and cortisol, and cortisol values at each time point of the ACTH test. Basal ACTH concentrations did not differ between admission time to the RICU and at follow-up seven days later. Basal cortisol concentrations and cortisol values during the LDT did not differ at the two time points during follow-up. The cortisol increment defined as a difference between maximal value and the values at each sampling time point did not differ between the two tests 7 days apart. In the whole group of patients, cortisol increment lower than 250 nmol/L during the ACTH test was found in 14 (25.9%) subjects on Day 0, and in 13 (24%) subjects on Day 7. In patients who died during the follow-up period, cortisol increment lower than 250 nmol/L was recorded in 3/5 subjects (60%).

APACHE II and SOFA scores were significantly associated with prediction of mortality during hospitalization in the RICU, and are related to the maximal cortisol increase during ACTH testing *[(Table II](#j_jomb-2016-0015_tab_002){ref-type="table"}* and *[Table III)](#j_jomb-2016-0015_tab_003){ref-type="table"}*. Female sex and maximal cortisol response on ACTH testing predicted duration of hospitalization in the RICU, namely, the higher the maximal cortisol response, the longer the period of hospitalization in the RICU *[(Table IV)](#j_jomb-2016-0015_tab_004){ref-type="table"}*. In the logistic regression, APACHE II and SOFA scores were the only significant variables associated with prediction of the overall survival outcome *[(Table V)](#j_jomb-2016-0015_tab_005){ref-type="table"}*.

###### 

Inflated Negative Binomial Regression analysis for the prediction of mortality using APACHE II score

  Variable                            Regression Coefficient (β)   SE      Odds Ration (95% Confidence Interval)   P Value
  ----------------------------------- ---------------------------- ------- --------------------------------------- ---------
  Count Model Coefficients                                                                                         
                                                                                                                   
  Intercept                           -0.085                       0.658   -0.130                                  0.896
                                                                                                                   
  Sex (female)                        -0.734                       0.504   -1.467                                  0.145
                                                                                                                   
  Maximal cortisol difference         0.005                        0.001   3.286                                   0.001
                                                                                                                   
  Zero-Inflation Model Coefficients                                                                                
                                                                                                                   
  Intercept                           19.696                       9.285   2.121                                   0.033
                                                                                                                   
  APACHE II                           -0.931                       0.470   -1.981                                  0.047

APACHE, acute physiology and chronic health evaluation.

###### 

Inflated Negative Binomial Regression analysis for the prediction of mortality using SOFA score.

  Variable                            Regression Coefficient (β)   SE      Odds Ratio (95% Confidence Interval)   P Value
  ----------------------------------- ---------------------------- ------- -------------------------------------- ---------
  Count Model Coefficients                                                                                        
                                                                                                                  
  Intercept                           -0.969                       1.010   -0.960                                 0.337
                                                                                                                  
  Sex (female)                        -4.122                       1.352   -3.048                                 0.002
                                                                                                                  
  Maximal cortisol difference         0.004                        0.001   3.348                                  \<0.001
                                                                                                                  
  Zero-Inflation Model Coefficients                                                                               
                                                                                                                  
  Intercept                           7.097                        3.090   2.296                                  0.021
                                                                                                                  
  SOFA                                -1.335                       0.732   -1.824                                 0.068

SOFA, sequential organ failure assessment.

###### 

Poisson regression analyses for the prediction of the duration of stay in RICU.

  Variable                       Regression Coefficient (β)   SE       Odds Ratio (95% Confidence Interval)   P Value
  ------------------------------ ---------------------------- -------- -------------------------------------- ---------
  Intercept                      0.986                        0.174    5.653                                  \<0.001
                                                                                                              
  Sex (female)                   -0.106                       0.190    -0.559                                 0.576
                                                                                                              
  Maximal cortisol difference    0.0004                       0.0002   1.967                                  0.049
                                                                                                              
  Inclusion of APACHE II score                                                                                
                                                                                                              
  Intercept                      0.400                        0.233    1.715                                  0.086
                                                                                                              
  Sex (female)                   -0.087                       0.192    -0.453                                 0.650
                                                                                                              
  Maximal cortisol difference    0.0001                       0.0002   0.391                                  0.696
                                                                                                              
  APACHE II                      0.048                        0.013    3.594                                  \<0.001
                                                                                                              
  Inclusion of SOFA score                                                                                     
                                                                                                              
  Intercept                      0.643                        0.207    3.101                                  0.001
                                                                                                              
  Sex (female)                   -0.065                       0.191    -0.343                                 0.731
                                                                                                              
  Maximal cortisol difference    0.0002                       0.0002   1.237                                  0.216
                                                                                                              
  SOFA                           0.113                        0.035    3.149                                  0.001

RICU, respiratory intensive care unit; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment.

###### 

Logistic regression analysis for the prediction of overall survival outcome.

  Variable                       Regression Coefficient (β)   SE      Odds Ratio (95% Confidence Interval)   P Value
  ------------------------------ ---------------------------- ------- -------------------------------------- ---------
  Inclusion of APACHE II score                                                                               
                                                                                                             
  Intercept                      -6.624                       1.817   -3.645                                 \<0.001
                                                                                                             
  APACHE II                      0.229                        0.079   2.874                                  0.004
                                                                                                             
  Inclusion of SOFA score                                                                                    
                                                                                                             
  Intercept                      -7.579                       2.327   -3.256                                 0.001
                                                                                                             
  SOFA                           1.095                        0.401   2.729                                  0.006

APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment.

Discussion {#j_jomb-2016-0015_s_004}
==========

Our study was designed to assess the response of cortisol after low-dose ACTH stimulation in patients admitted to the RICU because of a fully clinically defined state of SIRS due to a respiratory infection. Although we did not find differences in either basal cortisol values or at each time point of the ACTH test, a difference in the maximal cortisol response (Δ max) during the ACTH test before and after 7 days of follow-up was clearly shown. Moreover, Δ max predicted the duration of hospitalization in the RICU and in-hospital mortality outcome. The clinical scores APACHE II and SOFA, however, were shown to be the best predictors of duration of hospitalization, mortality outcome as well as overall survival outcome.

SIRS implies a clinical response to a nonspecific insult characterized with two or more of the defined variables, while sepsis represents SIRS with a documented infection. Consequently, multiple organ dysfunction syndrome (MODS) represents a sequel of SIRS and/or sepsis, and failure to maintain homeostasis without intervention. Hence, MODS is recognized as a sequel to SIRS, a continuum that includes the development of SIRS, onset of sepsis and progression to septic shock, and multiple organ dysfunction [@j_jomb-2016-0015_ref_015], and it is related to high mortality [@j_jomb-2016-0015_ref_016]. However, data on the prevalence of SIRS and sepsis are still lacking. According to some European analyses, severe infection is diagnosed in 16% of patients hospitalized in the ICU due to respiratory complications as the most common feature, with deadly outcome in approximately half of them [@j_jomb-2016-0015_ref_017].

Our group of patients had SIRS caused by a respiratory infection, and all of them continue their monitoring and treatment in the RICU. The mortality rate calculated from the APACHE II score was higher than the mortality recorded in our study. A possible explanation could be the design of the study that followed patients for seven days in comparison to other studies that followed patients for 28 days after the onset of SIRS or sepsis. Moreover, estimated organ dysfunction predicted by the SOFA score and the mortality rate predicted by the APACHE II score suggest possibly milder forms of SIRS at presentation within our group of patients.

It was observed that increased levels of plasma cortisol are related to higher risk of death in critically ill humans. Inappropriately low cortisol concentrations, however, were shown to be related to increased mortality as well [@j_jomb-2016-0015_ref_018]. A new clinical description of 'critical illness-related corticosteroid insufficiency' (CIRCI) was used to define higher cortisol levels in this condition in comparison to healthy status [@j_jomb-2016-0015_ref_019]. Diagnostic criteria for CIRCI in the critically ill were based on a cortisol incremental response of less than 9 mg/dL (250 nmol/L) after adrenal cortex stimulation with 250 μg ACTH, and this was considered the most discriminative for increased risk of death [@j_jomb-2016-0015_ref_020]. During the ACTH test, a cortisol increment lower than 250 nmol/L was observed in 14/54 (25.9%) of our patients. Similar prevalence of relative adrenal insufficiency or dysfunction (less than 25%) was observed in ICU patients with diagnosis other than septic shock [@j_jomb-2016-0015_ref_013]. In our group of patients, however, death as outcome was recorded in 3/5 (60%) of those with a cortisol increment lower than 250 nmol/L. Relatively lower values for deadly outcome in our patients could be related to the SIRS condition, in comparison to other studies that recorded deadly outcomes in 100% of patients with sepsis [@j_jomb-2016-0015_ref_021]. Moreover, the Δ maximal cortisol increment obtained in our study far exceeds the cutoff point increment proposed for the assessment of outcome of the critically ill ([@j_jomb-2016-0015_ref_020], [@j_jomb-2016-0015_ref_021]) and is in line with the low prevalence of relative adrenal insufficiency in our patients with SIRS. The D maximal cortisol increment could be used for the prediction of length of hospitalization in the RICU and mortality outcome. However, when included into the respective analyses, the scores APACHE II and SOFA best predicted the duration of hospitalization in the RICU, mortality outcome and overall survival outcome, and the same has been shown elsewhere ([@j_jomb-2016-0015_ref_002]--[@j_jomb-2016-0015_ref_003], [@j_jomb-2016-0015_ref_023]).

Taking into consideration the above facts about the adrenal axis changes during SIRS, a high sensitivity test should be performed for the diagnosis of adrenal cortex dysfunction. It was shown that LDT with 1 μg of ACTH is more sensitive for detecting mild secondary adrenal insufficiency, and is superior to the standard stimulation test with 250 μg of ACTH(10). The patients we investigated represented a natural model of secondary adrenal insufficiency. As expected, we showed low normal levels of ACTH at both time points (Day 0 and Day 7). Although cortisol concentrations during the ACTH test showed a trend towards decrease after seven days, they did not reach statistical significance. In the repeated test, however, only the maximal cortisol response during the ACTH test showed a clear decrease. Our results are in line with a recent study on ACTH and cortisol concentrations during the first seven days of ICU monitoring. Namely, morning ACTH was suppressed from admission to the intensive care unit and remained below the limit of normality during the first week of critical illness [@j_jomb-2016-0015_ref_024]. Although our results showed a similar pattern of low ACTH from the beginning of the follow-up period, it could be assumed that we had missed the initial ACTH response to stress prior to admission to the ICU, and the same was supposed by others as well [@j_jomb-2016-0015_ref_024]. This possibility was recently supported by the detection of low orexin activity in the hypothalamus during a prolonged phase of critical illness that happened 48 hours after the initial rise in ACTH [@j_jomb-2016-0015_ref_025].

Besides ACTH, the cortisol production rate in ICU patients was moderately increased but without the doubling of values that was observed in healthy subjects [@j_jomb-2016-0015_ref_024]. Moreover, cortisol production was elevated only in patients with SIRS, possibly mediated by the activity of cytokines ([@j_jomb-2016-0015_ref_001], [@j_jomb-2016-0015_ref_024]). Accordingly, low ACTH and high cortisol suggest that mechanisms other than those dependent on ACTH are responsible for the high cortisol concentrations during critical illness, namely, growth factors, corticotrophin releasing hormone and ACTH loop, immune system or the local vascular system characteristics ([@j_jomb-2016-0015_ref_026], [@j_jomb-2016-0015_ref_027]). Nevertheless, other possibilities such as suppressed cortisol clearance with consequently elevated plasma cortisol concentrations and suppressed ACTH release should also be considered [@j_jomb-2016-0015_ref_024].

Conclusion {#j_jomb-2016-0015_s_005}
==========

We showed a difference in the maximal cortisol response (D max) between two LDTs performed at the diagnosis of SIRS and seven days later. The D max, and primarily the clinical scores APACHE II and SOFA predicted clinical outcomes of hospitalization in the RICU, while the clinical scores also successfully predicted overall survival outcome. LDT represents a sensitive tool for detecting specific forms of adrenal insufficiency as it could be induced by the state of SIRS.
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SIRS

:   systemic inflammatory response syndrome

ACTH

:   adrenocorticotropin

APACHE

:   acute physiology and chronic health evaluation

SOFA

:   sequential organ failure assessment

ICU/RICU

:   intensive care unit/respiratory intensive care unit

LDT

:   low-dose test

ARDS

:   acute respiratory distress syndrome
